Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept

BACKGROUND: In de novo kidney transplant recipients (KTR) treatment with belatacept has been established as a comparable option as maintenance immunosuppression, preferably as a strategy to convert from calcineurin inhibitor (CNI)- to belatacept-based immunosuppression. Switch to belatacept demonstr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Nephrol
Main Authors: Choi, Mira, Bachmann, Friederike, Wu, Kaiyin, Lachmann, Nils, Schmidt, Danilo, Brakemeier, Susanne, Duerr, Michael, Kahl, Andreas, Eckardt, Kai-Uwe, Budde, Klemens, Nickel, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7439694/
https://ncbi.nlm.nih.gov/pubmed/32819287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-01992-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados